MRSA Surveillance Culture

Test Code
CXMRS


Alias/See Also
Epic: LAB234


Includes

Screening Culture for Methicillin Resistant Staphylococcus aureus (MRSA) for Infection Control Purposes




Preferred Specimen

Specimen Type: Swab
Source: Anterior nares, throat
Collection Container: E-Swab
Specimen Volume: Swab



 




Instructions

Nares

  1. Swab each nare 2-5 times by rotating swab firmly clockwise and counterclockwise against lining of the nasal mucosa.
  2. Aseptically unscrew and remove the cap from the ESwab with Liquid Amies Medium tube.
  3. Insert the swab into the tube and break the swab shaft at the breakpoint indicated by the colored line marked on the swab shaft. Discard the broken portion.
  4. Replace cap on the tube and secure tightly.
  5. Label specimen as Nares


Throat

  1. Swab throat.
  2. Aseptically unscrew and remove the cap from the ESwab with Liquid Amies Medium tube.
  3. Insert the swab into the tube and break the swab shaft at the breakpoint indicated by the colored line marked on the swab shaft. Discard the broken portion.
  4. Replace cap on the tube and secure tightly.
  5. Label specimen as throat.


Specimen Stability
Must be received within 48hrs of collection


Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Dry swabs received, improperly labeled specimen, insufficient volume, specimen not submitted in appropriate transport container


Methodology
Chromogenic MRSA Detection Media


Setup Schedule
Daily


Report Available

1-2 Days. Rarely, samples may require additional confirmatory testing which will increase time to result




Limitations

Surveillance testing determines the colonization status at the time of collection. Subsequent treatment or exposure to high risk environments (ex. contact with MRSA carrier or prolonged hospitalization) may cause colonization status to change. Use of phenylephrine hydrochloride or oxymetazoline hydrochloride components found in some nasal sprays have an inhibitory effect on organism growth.




Clinical Significance
This test is for infection control purposes only. A positive surveillance screen suggests that the patient is colonized with MRSA. It does not necessarily indicate that MRSA is causing an infection or that treatment for an infection needs to occur. The laboratory does not provide susceptibility testing results for MRSA isolates from screening cultures.


Performing Laboratory

Inova Laboratories

2832 Juniper Street

Fairfax, VA 22031




Last Updated: May 15, 2023
Last Review: N. Wolford, May 15, 2023


The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.